Investor · Newark, NJ

Thomas Beck

Open Thomas in the network graph →

Filings

8

SEC Form D

Connections

46

co-filers

Capital

$8.5M

across filings

Active

Nov 2013

to Dec 2019

Most-connected co-filers (46)

Klaus Veitinger · Newark, NJ3 shared Chad Beyer · Milwaukee, WI2 shared Patrick Schwarz-Schuette · Milwaukee, WI2 shared Stephen Tullman · Malvern, PA2 shared Daniel Lawton · Milwaukee, WI2 shared Anand Mehra · Menlo Park, CA2 shared Shad L. Stastney · Philadelphia, PA2 shared Thomas N. Littman · BEACHWOOD, OH2 shared Albert K. Cha · Redwood City, CA2 shared Christopher Powala · MALVERN, PA2 shared Stephen Squinto · HANOVER, NH2 shared Kevin A. Shields · El Segundo, CA2 shared Stacey M. Seltzer · Santa Clara, CA2 shared Neal C. Walker · Malvern, PA2 shared John Succo · New York, NY2 shared Timothy Hare · Suffolk, VA2 shared Michael T. Degrandis · Beachwood, OH2 shared Mary P. Higgins · El Segundo, CA2 shared Michael J. Escalante · El Segundo, CA2 shared Chris G. Cooper · Salt Lake City, UT1 shared Stacey Seltzer · Milwaukee, WI1 shared Joseph Amprey · Newark, NJ1 shared Robert Jacks · Newark, NJ1 shared Rishi Gupta · Cambridge, MA1 shared

Recent filings (8)

Promentis Pharmaceuticals, Inc.Dec 2019 · 13 co-filers$6.0M Promentis Pharmaceuticals, Inc.Dec 2019 · 13 co-filers$6.0M Promentis Pharmaceuticals, Inc.Oct 2016 · 19 co-filers$8.8M Symbiomix Therapeutics, LLCMay 2016 · 17 co-filers$6.0M Dimension Therapeutics, Inc.Nov 2013 · 2 co-filers$45.0M Dimension Therapeutics, Inc.Nov 2013 · 2 co-filers$45.0M Griffin Capital (Waterford) Investors, DSTJan 2011 · 5 co-filers$14.1M Vicept Therapeutics, Inc.Jun 2010 · 9 co-filers$15.8M Vicept Therapeutics, Inc.Aug 2009 · 9 co-filers$12.5M Griffin Capital (Waterford) Investors, DSTAug 2009 · 5 co-filers$14.1M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Thomas in the interactive graph →